# US 2011/0257108 A1 · Synthesis and activity of lactose esters

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0257108 A1
- Document ID: US20110257108A1
- Status: Published application
- Kind: A1
- Application number: 12/760,280
- Filed: 2010-04-14
- Published: 2011-10-20
- Earliest claimed: 2010-04-14
- Assignees: Utah State University
- Inventors: Marie K. Walsh
- Web page: https://patentgrep.com/patent/US20110257108A1

## CPC

- A23B 4/20: Organic compounds; Microorganisms; Enzymes
- A01N 43/16: with oxygen as the ring hetero atom
- A23B 2/75: with doubly-bound oxygen
- C07H 13/06: Fatty acids
- C12P 19/44: Preparation of O-glycosides, e.g. glucosides {(polysaccharides and not substituted disaccharides C12P19/04, C12P19/12)}
- C12Y 301/01003: Triacylglycerol lipase (3.1.1.3)
- A23B: PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

This disclosure provides for a novel lactose monolaurate (LML) with the structure useful as an antimicrobial agent and as a potential substitute for other sugar esters. Methods of synthesizing LML using immobilize lipases and various solvents are also provided.

## Claims

### Claim 1

A chemical compound, comprising, the following compound:

### Claim 2 (depends on 1)

A method of synthesizing the compound of claim 1, comprising:
(i) providing a first substrate, a second substrate, a solvent and an immobilized lipase, wherein the first substrate is lactose, and the second substrate is lauric acid, vinyl laurate, or a combination of lauric acid and vinyl laurate,
(ii) contacting the first substrate and the second substrate to the immobilized lipase in the presence of the solvent, wherein the contacting occurs in a nonaqueous mixture, and wherein the contacting may optionally occur in the presence of molecular sieves,
(iii) allowing the mixture to undergo biochemical reaction and form a reacted mixture at a temperature below the evaporation point of the solvent, wherein one product of the reaction is LML,
(iv) filtering the reacted mixture with a filter capable of removing a substantial amount of the immobilized lipase, unreacted first substrate, unreacted second substrate, and any optionally included molecular sieves,
(iv) drying the reacted mixture,
(v) resuspending the reacted mixture in a solution comprising an alcohol, wherein the resuspending may result in the formation of a solution phase and a lipid phase, and wherein the resuspending may result in some precipitation of unreacted first substrate, and may also result in unreacted second substrate in the lipid phase, and wherein most of the LML product is within the solution phase,
(vi) substantially separating the solution phase from the precipitated first substrate and second substrate, and also separating the solution phase from the lipid phase, such that a solution phase comprising LML is substantially isolated,
(vii) optionally confirming the purity of the LML in the solution phase by HPLC.

### Claim 3 (depends on 2)

The method of claim 2, wherein said temperature is kept between 50° C. and 70° C.

### Claim 4 (depends on 2)

The method of claim 2, wherein said immobilized lipase is one or more lipase or lipases selected from a group comprising TL, MM, PC, or CA.

### Claim 5 (depends on 2)

The method of claim 2, wherein said solvent is one or more solvents selected from a group comprising 2M2B, acetone, or MEK.

### Claim 6 (depends on 2)

The method of claim 2, wherein an initial concentration of lactose is sufficiently high such that at least a substantial amount of the lactose is an insolubilized lactose, and wherein the synthesis of LML results in solubilization of the insolubilized lactose, wherein the solubilization of the insolubilized lactose contributes to the overall yield of LML.

### Claim 7 (depends on 2)

The method of claim 2, wherein said immobilized lipase is MM and wherein the concentration of the MM is between 1.72 mg/ml and 50 mg/ml, and wherein said solvent is 2M2B, and wherein said temperature is kept between 18° C. and 61° C., and wherein the ratio of lactose to vinyl luarate is between 1:0.17 and 1:5.83.

### Claim 8 (depends on 2)

The method of claim 2, wherein the limiting reactant is lactose.

### Claim 9 (depends on 2)

The method of claim 2, wherein said immobilized lipase is TL and said solvent is acetone.

### Claim 10 (depends on 2)

The method of claim 2, wherein said immobilized lipase is one or more lipase or lipases selected from a group comprising TL, MM, PC, or CA, and wherein said solvent is one or more solvents selected from a group comprising 2M2B, acetone, of MEK.

### Claim 11 (depends on 10)

The method of claim 10, wherein said temperature is kept between 50° C. and 70° C.

### Claim 12 (depends on 10)

The method of claim 10, wherein said immobilized lipase is one or more lipase or lipases selected from a group comprising TL, MM, PC, or CA.

### Claim 13 (depends on 10)

The method of claim 10, wherein said solvent is one or more solvents selected from a group comprising 2M2B, acetone, of MEK.

### Claim 14 (depends on 10)

The method of claim 10, wherein an initial concentration of lactose is sufficiently high such that at least a substantial amount of the lactose is an insolubilized lactose, and wherein the synthesis of LML results in solubilization of the insolubilized lactose, wherein the solubilization of the insolubilized lactose contributes to the overall yield of LML.

### Claim 15 (depends on 10)

The method of claim 10, wherein said immobilized lipase is MM and wherein the concentration of the MM is between 1.72 mg/ml and 50 mg/ml, and wherein said solvent is 2M2B, and wherein said temperature is kept between 18° C. and 61° C., and wherein the ratio of lactose to vinyl luarate is between 1:0.17 and 1:5.83.

### Claim 16 (depends on 10)

The method of claim 10, wherein the limiting reactant is lactose.

### Claim 17 (depends on 10)

The method of claim 10, wherein said immobilized lipase is TL and said solvent is acetone.

### Claim 18

A method of inhibiting, preventing, reducing or eliminating the presence or growth of a microorganism on a surface, comprising: contacting the surface with an antimicrobial composition comprising, a sufficient amount of LML at a sufficient concentration and for a sufficient period of time to inhibit, prevent, reduce or eliminate the presence or growth of a microorganism susceptible to the antimicrobial activity of LML.

### Claim 19 (depends on 20)

The method of claim 20, wherein said gram positive bacteria is selected from a group comprising: Enterococcus faecalis, Listeria monocytogenes and Streptococcus suis.

### Claim 20 (depends on 20)

The method of claim 20, wherein the surface further comprising the surface of a food product.
